Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 22 relevant journals, 25 Conferences are presently dedicated exclusively to Pulmonary embolism and about 29 articles are being published on Pulmonary embolism.
Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood clot. In most cases, the clots are small and are not deadly, but they can damage the lung. But if the clot is large and stops blood flow to the lung, it can be deadly. Pulmonary emboli usually arise from thrombi that originate in the deep venous system of the lower extremities; however, they rarely also originate in the pelvic, renal, upper extremity veins, or the right heart chambers. After traveling to the lung, large thrombi can lodge at the bifurcation of the main pulmonary artery or the lobar branches and cause hemodynamic compromise
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Pulmonary embolism is a serious condition that can cause Permanent damage to the affected lung, low oxygen levels in your blood, damage to other organs in your body from not getting enough oxygen. Pulmonary embolisms are treated with anticoagulant medicines. These stop the blood clot getting bigger while your body slowly reabsorbs it, and reduce your risk of further clots developing. Blood-thinning medication may be given, especially in patients with severe symptoms. This is given through an IV, injected into the skin directly, or taken by mouth.
A pulmonary embolism is often caused by a blood clot travelling up from one of the deep veins in your legs to your heart and lungs. Pulmonary embolisms are treated with anticoagulant medicines. These stop the blood clot getting bigger while your body slowly reabsorbs it, and reduce your risk of further clots developing.
A number of methods may be recommended to prevent a pulmonary embolism if you're at risk of developing blood clots. These include:
Market Analysis:
The global anticoagulant drug market was valued at nearly $5.8 billion in 2011 and should reach nearly $5.7 billion in 2012. Total market value is expected to reach nearly $5.4 billion in 2017 after decreasing at a five-year compound annual growth rate (CAGR) of -1.1%.
International symposium and workshops:
List of Best International Conferences:
Relevant Society and Associations
Companies
This page will be updated regularly.
This page was last updated on November 5, 2024
